Sanofi Ambien patent

03 Mar 2003
News

Executive Summary

Sanofi will list Ambien patent covering modified-release version of insomnia agent in FDA's "Orange Book," company says. Patent for zolpidem MR (no. 6,514,531) would run to 2019; Ambien exclusivity currently expires in 2006. Sanofi plans to file in 2004 for FDA approval (1"The Pink Sheet" Feb. 24, p. 15)...

Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS041368

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS041368

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Sanofi Ambien patent

News

Executive Summary

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sanofi Ambien patent

News

Executive Summary

Related Content

Sanofi Ambien Line Extension Planned For 2004; Still Confident In Arixtra

Sanofi Ambien Line Extension Planned For 2004; Still Confident In Arixtra

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert